The Maddening Saga Of How An Alzheimer’s ‘cabal’ Thwarted Progress Toward A Cure For Decades

Thanks Sharon for a timely article and thanks for interviewing me. But the biggest problem with addressing “Alzheimer’s” is not that amyloid has become a pharmaceutical target of exaggerated importance, but that pharmaceutical approaches are themselves viewed as the best way to prevent dementia and improve quality of life of people today and in the future. So-called Alzheimers is not one condition and dementia is related to aging. Public health, educational, and arts approaches embedded in community will continue to better address our social and ecological challenges, not only having to do with dementia but in general. Neoliberal politics have created vast social and economic inequities that contribute to social determinants of poor brain and general health. We need to not only recognize that we have poorly thought through, bad ideas about the role of amyloid in the brain but worst conceptions of Alzheimer’s in our minds and societies.

The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades
Patent office reopens major CRISPR battle between Broad Institute and Univ. of California
Role of seizures in Alzheimer’s disease is gaining overdue attention
Daily on Healthcare, presented by FreedomWorks: Student debt is keeping doctors from rural areas
Recon: AbbVie to Acquire Allergan for $63B
This pill prevents HIV. Why don’t more people take it?
Gaza: 300 Yards Between Life And Death
Why Women Hate Hillary
The Goldfinch: A Novel
The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades